Design and implementation of clinical trials (Phases I-III) across multiple countries including Australia, Korea, Malaysia, Thailand, and India.
Engagement with regulatory bodies, CROs, and ethics committees for trial approvals and compliance.
Scientific support for pre-launch, launch, and post-launch phases of innovative pharmaceutical products.
Training and development of sales and marketing teams with evidence-based insights and scientific strategies.
Real-world data generation and local evidence development for enhancing product positioning and lifecycle management.
Establishing advisory boards and building KOL networks to guide brand development and support clinical programs.
Conducting impactful CME programs, symposia, and investigator meetings to bridge science with clinical practice.
© Argus Medical Affairs Consultancy. All rights reserved.